# Axcelis Technologies Inc: Form 10-Q for the period ended Mar 31, 2015

- Company: [Axcelis Technologies Inc](/companies/acls.md) (CIK 1113232)
- Form: 10-Q
- Filed: 2015-05-06
- Accepted by EDGAR: May 6, 2015, 16:14 ET
- Period: 2015-03-31
- Accession: 0001104659-15-034879
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1113232/000110465915034879/a15-6960_110q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1113232/000110465915034879/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2015-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2015-01-01 to 2015-03-31 | $73.3m | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months, 2015-01-01 to 2015-03-31 | $49.9m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2015-01-01 to 2015-03-31 | $23.4m | us-gaap:GrossProfit |
| Research and development | 3 months, 2015-01-01 to 2015-03-31 | $8.2m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2015-01-01 to 2015-03-31 | $3.4m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2015-01-01 to 2015-03-31 | $1.0m | us-gaap:InterestExpense |
| Income tax | 3 months, 2015-01-01 to 2015-03-31 | $101.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2015-01-01 to 2015-03-31 | $1.9m | us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic |
| Diluted EPS | 3 months, 2015-01-01 to 2015-03-31 | $0.02 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2015-01-01 to 2015-03-31 | $0.02 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2015-01-01 to 2015-03-31 | 118,720,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2015-01-01 to 2015-03-31 | $8.7m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 3 months, 2015-01-01 to 2015-03-31 | $320.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2015-03-31 | $74.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2015-03-31 | $234.4m | us-gaap:AssetsCurrent |
| Total assets | at 2015-03-31 | $276.2m | us-gaap:Assets |
| Current liabilities | at 2015-03-31 | $50.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2015-03-31 | $104.9m | us-gaap:Liabilities |
| Shareholders' equity | at 2015-03-31 | $171.3m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 21,563 characters.

### Overview

The semiconductor capital equipment industry is subject to significant cyclical swings in capital spending by semiconductor manufacturers. Capital spending is influenced by demand for semiconductors and the products using them, the utilization rate and capacity of existing semiconductor manufacturing facilities and changes in semiconductor technology, all of which are outside of our control. As a result, our revenue and gross margins fluctuate from year to year and period to period. Our established cost structure does not vary significantly with changes in volume. We may experience fluctuations in operating results and cash flows depending on our revenue as driven by the level of capital expenditures by semiconductor manufacturers as well as by customer demand for our products in comparison to alternative capital equipment.

Consolidation and partnering within the semiconductor manufacturing industry has resulted in a small number of customers representing a substantial portion of our business. Our net revenue from our ten largest customers accounted for 80.8% of total revenue for the three months ended March 31, 2015 compared to 81.2% of revenue for the three months ended March 31, 2014.

A successful semiconductor equipment manufacturer must not only provide some of the most technically complex products manufactured in the world but also must design its business to thrive during the inevitable low points in the cycle. Our recent financial results reflect increasing sales of our innovative Purion ion implantation systems, and our continued investment in research and development programs related to our Purion ion implantation products.

During the first quarter of 2015 the Company made significant progress towards its market share goals as a result of rising Purion platform sales, including both new penetrations and multiple follow on orders, and growth in the memory and non-leading edge foundry and logic segments. Throughout 2015 we expect to continue to grow Purion system sales and maintain tight control of our cost structure.

### Critical Accounting Estimates

Management’s discussion and analysis of our financial condition and results of operations included herein and in our Annual Report on Form 10-K for the year ended December 31, 2014 are based upon Axcelis’ consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates and assumptions. Management’s estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

Management has not identified any need to make any material change in, and has not changed, any of our critical accounting estimates and judgments as described in Management’s Discussion and Analysis of Financial Conditions and Results of Operations included in our Annual Report on Form 10-K for the year ended December 31, 2014.

### Results of Operations

The following table sets forth our results of operations as a percentage of total revenue:

| Revenue: | Three months ended March 31, 2015 | 2014 |
| --- | ---: | ---: |
| Product | 92.1% | 90.4% |
| Services | 7.9 | 9.6 |
| Total revenue | 100.0 | 100.0 |
| Cost of revenue: |  |  |
| Product | 61.7 | 55.6 |
| Services | 6.4 | 8.7 |
| Total cost of revenue | 68.1 | 64.3 |
| Gross profit | 31.9 | 35.7 |
| Operating expenses: |  |  |
| Research and development | 11.2 | 15.2 |
| Sales and marketing | 7.7 | 9.0 |
| General and administrative | 8.3 | 10.7 |
| Restructuring charges | 0.0 | 0.3 |
| Total operating expenses | 27.2 | 35.2 |
| Income from operations | 4.7 | 0.5 |
| Other (expense) income: |  |  |
| Interest income | — | — |
| Interest expense | (1.4) | (0.4) |
| Other, net | (0.6) | 0.5 |
| Total other (expense) income | (2.0) | 0.1 |
| Income before income taxes | 2.7 | 0.6 |
| Income taxes | 0.1 | 0.3 |
| Net income | 2.6% | 0.3% |

### Revenue

The following table sets forth our revenue.

*(dollars in thousands)*

| Revenue: | Three months ended March 31, 2015 | 2014 | Period-to-Period change $% |  |
| --- | ---: | ---: | ---: | ---: |
| Product | $67,530 | $55,015 | $12,515 | 22.7% |
| Percentage of revenue | 92.1% | 90.4% |  |  |
| Services | 5,753 | 5,825 | (72) | (1.2)% |
| Percentage of revenue | 7.9% | 9.6% |  |  |
| Total revenue | $73,283 | $60,840 | $12,443 | 20.5% |

#### Three Months Ended March 31, 2015 Compared with Three Months Ended March 31, 2014

#### Product

Product revenue which includes system sales, sales of spare parts, product upgrades and used systems was $67.5 million, or 92.1% of revenue during the three months ended March 31, 2015, compared with $55.0 million, or 90.4% of revenue for the three months ended March 31, 2014. The $12.5 million increase in product revenue for the three month period ending March 31, 2015 was primarily driven by an increase in the number of Purion systems sold.

A portion of our revenue from system sales is deferred until installation and other services related to future deliverables are performed. The total amount of deferred revenue at March 31, 2015 and December 31, 2014 was $8.7 million and $7.2 million, respectively. The increase is due to the timing of the acceptance of deferred system sales.

#### Services

Services revenue, which includes the labor component of maintenance and service contracts and fees for service hours provided by on-site service personnel, was $5.8 million, or 7.9% of revenue for the three months ended March 31, 2015, flat compared with $5.8 million, or 9.6%, of revenue for the three months ended March 31, 2014. Although services revenue typically increases with the expansion of the installed base of systems, it can fluctuate from period to period based on capacity utilization at customers’ manufacturing facilities, which affects the need for equipment service.

### Revenue Categories used by Management

As an alternative to the line item revenue categories discussed above, management also uses revenue categorizations which look at revenue by systems and aftermarket as described below.

#### Three Months Ended March 31, 2015 Compared with Three Months Ended March 31, 2014

#### Systems

Included in total revenue of $73.3 million during the three months ended March 31, 2015 is revenue from sales of new systems of $42.5 million, or 58.0% of total revenue, compared with $32.5 million, or 53.4%, of total revenue for the three months ended March 31, 2014. The increase was due to higher sales of our Purion systems, reflecting market share gains and an improved semiconductor equipment market.

#### Aftermarket

We refer to the business of selling spare parts, product upgrades and used systems, combined with the sale of maintenance labor and service contracts and service hours, as the “aftermarket” business. Included in total revenue of $73.3 million during the three months ended March 31, 2015 is revenue from our aftermarket business of $30.8 million, compared to $28.3 million for the three months ended March 31, 2014. Aftermarket revenue generally increases with the expansion of the installed base of systems, but can fluctuate from period to period based on capacity utilization at customers’ manufacturing facilities which affects the sale of spare parts and demand for equipment service.

### Gross Profit / Gross Margin

The following table sets forth our gross profit / gross margin.

*(dollars in thousands)*

| Gross Profit: | Three months ended March 31, 2015 | 2014 | Period-to-Period change $% |  |
| --- | ---: | ---: | ---: | ---: |
| Product | $22,345 | $21,213 | $1,132 | 5.3% |
| Product gross margin | 33.1% | 38.6% |  |  |
| Services | 1,035 | 527 | 508 | 96.4% |
| Services gross margin | 18.0% | 9.0% |  |  |
| Total gross profit | $23,380 | $21,740 | $1,640 | 7.5% |
| Gross margin | 31.9% | 35.7% |  |  |

#### Three Months Ended March 31, 2015 Compared with Three Months Ended March 31, 2014

#### Product

Gross margin from product revenue was 33.1% for the three months ended March 31, 2015, compared to 38.6% for the three months ended March 31, 2014. The decrease in gross margin of 5.5 percentage points resulted from the net effect of higher systems sales volume of new Purion systems at lower margins and a decreased mix of parts and upgrade revenue.

#### Services

Gross margin from services revenue was 18.0% for the three months ended March 31, 2015, compared to 9.0% for the three months ended March 31, 2014. The increase in gross margin is attributable to changes in the mix of service contracts and lower overall service costs.

### Operating Expenses

The following table sets forth our operating expenses:

*(dollars in thousands)*

|  | Three months ended March 31, 2015 | 2014 | Period-to-Period change $% |  |
| --- | ---: | ---: | ---: | ---: |
| Research and development | $8,199 | $9,257 | $(1,058) | (11.4)% |
| Percentage of revenue | 11.2% | 15.2% |  |  |
| Sales and marketing | 5,628 | 5,476 | 152 | 2.8% |
| Percentage of revenue | 7.7% | 9.0% |  |  |
| General and administrative | 6,101 | 6,481 | (380) | (5.9)% |
| Percentage of revenue | 8.3% | 10.7% |  |  |
| Restructuring charges | 10 | 200 | (190) | (95.0)% |
| Percentage of revenue | 0.0% | 0.3% |  |  |
| Total operating expenses | $19,938 | $21,414 | $(1,476) | (6.9)% |
| Percentage of revenue | 27.2% | 35.2% |  |  |

Our operating expenses consist primarily of personnel costs, including salaries, commissions, bonuses, share-based compensation and related benefits and taxes; project material costs related to the design and development of new products and enhancement of existing products; and professional fees, travel and depreciation expenses. At $8.6 million, personnel costs are our largest expense, representing 43.0% of our total operating expenses for the three months ended March 31, 2015, as compared to $12.6 million, or 59.5%, for the three months ended March 31, 2014.

### Research and Development

*(dollars in thousands)*

|  | Three months ended March 31, 2015 | 2014 | Period-to-period change $% |  |
| --- | ---: | ---: | ---: | ---: |
| Research and development | $8,199 | $9,257 | $(1,058) | (11.4)% |
| Percentage of revenue | 11.2% | 15.2% |  |  |

Our ability to remain competitive depends largely on continuously developing innovative technology, with new and enhanced features and systems, and introducing them at competitive prices on a timely basis. Accordingly, based on our strategic plan, we establish annual R&D budgets to fund programs that we expect will drive competitive advantages.

#### Three Months Ended March 31, 2015 Compared with Three Months Ended March 31, 2014

Research and development expense was $8.2 million during the three months ended March 31, 2015; a decrease of $1.1 million, or 11.4%, compared with $9.3 million during the three months ended March 31, 2014. The decrease was due to lower personnel costs driven by reduced headcount from the previous year.

### Sales and Marketing

*(dollars in thousands)*

|  | Three months ended March 31, 2015 | 2014 | Period-to-period change $% |  |
| --- | ---: | ---: | ---: | ---: |
| Sales and marketing | $5,628 | $5,476 | $152 | 2.8% |
| Percentage of revenue | 7.7% | 9.0% |  |  |

Our sales and marketing expenses result primarily from the sale of our equipment and services through our direct sales force.

#### Three Months Ended March 31, 2015 Compared with Three Months Ended March 31, 2014

Sales and marketing expense was $5.6 million during the three months ended March 31, 2015; an increase of $0.2 million, or 2.8%, relatively flat compared with $5.5 million during the three months ended March 31, 2014.

### General and Administrative

*(dollars in thousands)*

|  | Three months ended March 31, 2015 | 2014 | Period-to-period change $% |  |
| --- | ---: | ---: | ---: | ---: |
| General and administrative | $6,101 | $6,481 | $(380) | (5.9)% |
| Percentage of revenue | 8.3% | 10.7% |  |  |

Our general and administrative expenses result primarily from the costs associated with our executive, finance, information technology, legal and human resource functions.

#### Three Months Ended March 31, 2015 Compared with Three Months Ended March 31, 2014

General and administrative expense was $6.1 million during the three months ended March 31, 2015; a decrease of $0.4 million, or 5.9%, compared with $6.5 million during the three months ended March 31, 2014. The decrease was primarily due to a reduction in personnel costs associated with a reduction in headcount.

### Restructuring Charges

*(dollars in thousands)*

|  | Three months ended March 31, 2015 | 2014 | Period-to-period change $% |  |
| --- | ---: | ---: | ---: | ---: |
| Restructuring charges | $10 | $200 | $(190) | (95.0)% |
| Percentage of revenue | 0.0% | 0.3% |  |  |

#### Three Months Ended March 31, 2015 Compared with Three Months Ended March 31, 2014

We implemented reductions in force in prior periods to improve the focus of our operations, control costs, achieve future profitability and conserve cash. As a result of these actions, we recorded a minor adjustment to restructuring expense in the quarter ended March 31, 2015 compared to $0.2 million during the three month period ended March 31, 2014.

### Other (Expense) Income

#### Three Months Ended March 31, 2015 Compared with Three Months Ended March 31, 2014

Other expense was $1.5 million for the three months ended March 31, 2015 compared with other income of $0.1 million for the three months ended March 31, 2014. Other (expense) income consists primarily of foreign exchange gains and losses attributable to fluctuations of the U.S. dollar against the local currencies of certain of the countries in which we operate, interest earned on our invested cash balances, bank fees associated with our financing arrangements and interest expense related to financing arrangements. The increase in other expense was primarily driven by charges incurred relating to the sale of our corporate headquarters facility. The Company recorded $0.9 million in interest expense associated with the lease of our headquarters in Beverly, which is being accounted for as a financing obligation. See Note 3 for further discussion. The Company also recorded $0.3 million in expense related to prepayment charges associated with the satisfaction of our term loan with Northern Bank & Trust Company.

During the three month periods ended March 31, 2015 and 2014, with the exception of the lease agreement entered into by the Company relating to the sale leaseback transaction, we had no significant off-balance-sheet risks such as foreign exchange contracts, option contracts or other foreign hedging arrangements.

### Income Tax Provision

*(dollars in thousands)*

|  | Three months ended March 31, 2015 | 2014 | Period-to-period change $% |  |
| --- | ---: | ---: | ---: | ---: |
| Income tax provision | $101 | $195 | $(94) | (48.2)% |
| Percentage of revenue | 0.1% | 0.3% |  |  |

We incur income tax expense relating principally to operating results of foreign entities in Europe and Asia, where we earn taxable income. We have significant net operating loss carryforwards in the United States and certain European tax jurisdictions and, as a result, we do not currently pay significant income taxes in those jurisdictions. Additionally, we do not recognize the tax benefit for such losses in the United States and certain European taxing jurisdictions, and will not do so until we have sufficient income such that these tax benefits can be utilized. As stated in Note 3, the Company does not anticipate incurring any material federal or state tax liability associated with the taxable gain on the sale of its corporate headquarters. The Company will continue to maintain a full valuation allowance for these tax assets until sustainable future levels of profitability are evident.

### Liquidity and Capital Resources

Our liquidity is affected by many factors. Some of these relate specifically to the operations of our business, for example, the rate of sale of our products, and others relate to the uncertainties of global economies, including the availability of credit and the condition of the overall semiconductor equipment industry. Our established cost structure, other than cost of goods sold, does not vary significantly with changes in volume. We experience fluctuations in operating results and cash flows depending on these changes in revenue levels.

During the three month period ended March 31, 2015, the Company generated $8.7 million of cash from operating activities. This was predominately driven by the Company’s income from operations, excluding non-cash charges such as depreciation and amortization and stock based compensation expense. The Company also had increases in accounts payable and other current liabilities and deferred revenue of approximately $12.9 million, offset by the increases in inventory and prepaid expenses and other current assets of approximately $8.0 million, resulting in a $4.9 million increase in cash from operations. In comparison, during the three month period ended March 31, 2014, the Company used $4.0 million of cash to support operating activities.

Investing activities for the three months periods ending March 31, 2015 and 2014 included $0.3 million and $0.2 million, respectively, used for capital expenditures.

Financing activities for the three month period ending March 31, 2015 provided net cash of $34.9 million, primarily due to $48.9 million of gross proceeds, less $0.4 million for prepaid rent, for a net amount of $48.5 million, from the sale of our corporate headquarters building in Beverly, Massachusetts. The Company also incurred $0.8 million of related financing costs paid in the first quarter of 2015 associated with the sale of our corporate headquarters. The Company paid $14.5 million relating to a scheduled principal payment, and upon the sale of corporate headquarters, the retirement of, our term loan with Northern Bank & Trust Company. Also included in cash provided by financing activities was $0.9 million received relating to the exercise of stock options and a $0.8 million decrease in our restricted cash balance. In comparison, financing activities for the three month period ending March 31, 2014 included $1.3 million of cash received upon exercise of stock options.

Our revolving credit facility with Silicon Valley Bank provides for borrowings of up to $10.0 million on a revolving basis during a two year term ending October 31, 2015, based primarily on accounts receivable. The Company’s ability to borrow under this line of credit is limited to 80% of the then current amount of qualified accounts receivable. As of March 31, 2015, the Company had not drawn down on the line of credit, although a portion of the availability is being used to support outstanding letters of credit in the amount of $6.9 million. At March 31, 2015, our available borrowing capacity under the credit facility was $3.1 million and we were in compliance with all covenants related to the credit facility. The revolving credit facility is used by the Company to support letters of credit and for short-term borrowing, as needed.

We believe that based on our current market, revenue, expense and cash flow forecasts, our existing cash, cash equivalents and borrowing capacity will be sufficient to satisfy our anticipated cash requirements for the short and long-term. In the event that demand for our products declines in future periods, we believe we can align manufacturing and operating spending levels to the changing business conditions and provide sufficient liquidity to support operations. Our expectation for adequate liquidity is subject to risks that may cause our actual results to differ materially from our expectations. These risks include the timing and degree of customer acceptance of our products, the continuing demand for ion implantation equipment, overall activity levels of semiconductor manufacturing, competitive pressure on sales and pricing, increases in material and other production costs that cannot be recouped in product pricing and global economic, political and financial conditions.

### Commitments and Contingencies

Other than the lease obligation related to the sale leaseback of our Corporate headquarters shown in the table below, significant commitments and contingencies at March 31, 2015 are consistent with those discussed in Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and Note 16 to the consolidated financial statements in our Annual Report on Form 10-K for the fiscal year ended December 31, 2014.

The following represents all material changes from our prior year end to our contractual obligations as of March 31, 2015 (in thousands):

| Contractual Obligations | Total | Payments Due by Period 2015 | 2016-2019 | 2020-2037 |
| --- | ---: | ---: | ---: | ---: |
| Lease obligation | $134,286 | $3,525 | $21,194 | $109,567 |
| Total | $134,286 | $3,525 | $21,194 | $109,567 |

20

## Market risk

As filed, 200 characters.

As of March 31, 2015, there have been no material changes to the quantitative information about market risk disclosed in Item 7A to our Annual Report on Form 10-K for the year ended December 31, 2014.

## Controls and procedures

As filed, 1,033 characters.

### Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) as of the end of the period covered by this report (the “Evaluation Date”). Based on this evaluation, our principal executive officer and principal financial officer concluded that, as of the Evaluation Date, these disclosure controls and procedures are effective.

### Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) identified in connection with the evaluation of our internal control that occurred during the three months ended March 31, 2015 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 170 characters.

As of March 31, 2015, there have been no material changes to the risk factors described in Item 1A to our Annual Report on Form 10-K for the year ended December 31, 2014.

Filed May 6, 2015.
Source: SEC EDGAR, the filing index for accession 0001104659-15-034879. Last ingested by Listed: Nov 13, 2026, 17:24 ET. No prices; not investment advice.
